The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Global tuberculosis incidence has declined marginally over the past decade, and
tuberculosis remains out of control in several parts of the world including Africa and Asia …
tuberculosis remains out of control in several parts of the world including Africa and Asia …
Tuberculous meningitis
Tuberculosis remains a global health problem, with an estimated 10.4 million cases and 1.8
million deaths resulting from the disease in 2015. The most lethal and disabling form of …
million deaths resulting from the disease in 2015. The most lethal and disabling form of …
Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America …
Prevention, European Respiratory Society, and Infectious Diseases Society of America …
Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection
C Orkin, K Arasteh… - … England Journal of …, 2020 - Mass Medical Soc
Background Long-acting injectable regimens may simplify therapy for patients with human
immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3 …
immunodeficiency virus type 1 (HIV-1) infection. Methods We conducted a phase 3 …
Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …
P Nahid, SE Dorman, N Alipanah… - Clinical infectious …, 2016 - academic.oup.com
Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …
Infectious Diseases Society of America jointly sponsored the development of this guideline …
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority …
DA Margolis, J Gonzalez-Garcia, HJ Stellbrink, JJ Eron… - The Lancet, 2017 - thelancet.com
Background Cabotegravir and rilpivirine are antiretroviral drugs in development as long-
acting injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus …
acting injectable formulations. The LATTE-2 study evaluated long-acting cabotegravir plus …
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel
Importance New data and therapeutic options warrant updated recommendations for the use
of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …
of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. Objective To …
[PDF][PDF] Guidelines for treatment of drug-susceptible tuberculosis and patient care
World Health Organization - 2017 - apps.who.int
In order to support countries in their effort to respond to the challenges posed by the TB
epidemic over the years, WHO has produced and regularly updated guidelines for the …
epidemic over the years, WHO has produced and regularly updated guidelines for the …
Cryptococcosis
EK Maziarz, JR Perfect - Infectious disease clinics, 2016 - id.theclinics.com
Cryptococcosis is an infectious disease with worldwide distribution and wide array of clinical
presentations caused by pathogenic encapsulated yeasts in the genus Cryptococcus …
presentations caused by pathogenic encapsulated yeasts in the genus Cryptococcus …
Advances in the development of new tuberculosis drugs and treatment regimens
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid,
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …